SI-BONE, Inc. (NASDAQ:SIBN) is one of the stocks Jim Cramer answered questions about. Inquiring about the stock, a caller mentioned that it has declined around 30% since they last asked about it in January. In response, Cramer said:

Gee, I don’t know. That’s, whoa, they’re losing too much money. We’re in a tough tape. We’re not going to buy the money losers. We got a lot of stocks that are making a lot of money. They’re way down now. That’s where we’re going to look at.

Stock market reports printed on a sheet of paper. Photo by RDNE Stock Project on Pexels

SI-BONE, Inc. (NASDAQ:SIBN) develops and sells medical devices for musculoskeletal disorders of the sacropelvic area, including minimally invasive implants for sacroiliac joint dysfunction, pelvic trauma, and spinal support. A caller inquired about the stock during the January 6 episode. Cramer responded:

Yeah, okay, so, you have to understand, this is a great, great speculation, I mean, terrific. And I’m glad you brought it to our viewers’ attention. I myself am going to huddle with research director Ben Stoto… and we are going to get to the bottom of this because I keep hearing this company’s name over and over and over again.

While we acknowledge the potential of SIBN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT:  33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None.  Follow Insider Monkey on Google News.